Loading [MathJax]/jax/output/SVG/jax.js
Review Topical Sections

CCL21-DC tumor antigen vaccine augments anti-PD-1 therapy in lung cancer

  • Targeting inhibitory immune checkpoint molecules has highlighted the need to find approaches enabling the induction and activation of an immune response against cancer. Therapeutic vaccination, which can induce a specific immune response against tumor antigens, is an important approach to consider. Although this approach has shown low clinical efficacy when combined with other treatment modalities, therapeutic cancer vaccines will have a better outcome when combined with immune checkpoint blockade therapy with potential for cancer free survival. In this review, we will discuss the results of our two recent publications in preclinical lung cancer models. Our studies reveal that anti-PD-1 administered in combination with CCL21-DC tumor antigen therapeutic vaccines eradicate lung cancer. The results of these studies highlight the importance of combination therapy of immune checkpoint blockade and therapeutic cancer vaccines for lung cancer patients.

    Citation: Sherven Sharma, Pournima Kadam, Ram P Singh, Michael Davoodi, Maie St John, Jay M Lee. CCL21-DC tumor antigen vaccine augments anti-PD-1 therapy in lung cancer[J]. AIMS Medical Science, 2021, 8(4): 269-275. doi: 10.3934/medsci.2021022

    Related Papers:

    [1] Junhua Guo, Bin Hua, Na Li, John Yang . Stabilizing lead bullets in shooting range soil by phosphate-based surface coating. AIMS Environmental Science, 2016, 3(3): 474-487. doi: 10.3934/environsci.2016.3.474
    [2] Jerry R. Miller, John P. Gannon, Kyle Corcoran . Concentrations, mobility, and potential ecological risks of selected metals within compost amended, reclaimed coal mine soils, tropical South Sumatra, Indonesia. AIMS Environmental Science, 2019, 6(4): 298-325. doi: 10.3934/environsci.2019.4.298
    [3] Voke O. Urhibo, Bernard O. Ejechi . Crude oil degradation potential of bacteria isolated from oil-polluted soil and animal wastes in soil amended with animal wastes. AIMS Environmental Science, 2017, 4(2): 277-286. doi: 10.3934/environsci.2017.2.277
    [4] Emitt C. Witt III . Use of lidar point cloud data to support estimation of residual trace metals stored in mine chat piles in the Old Lead Belt of southeastern, Missouri. AIMS Environmental Science, 2016, 3(3): 509-524. doi: 10.3934/environsci.2016.3.509
    [5] Carlos Garcia, Teresa Hernandez, Maria D Coll, Sara Ondoño . Organic amendments for soil restoration in arid and semiarid areas: a review. AIMS Environmental Science, 2017, 4(5): 640-676. doi: 10.3934/environsci.2017.5.640
    [6] Martina Grifoni, Francesca Pedron, Gianniantonio Petruzzelli, Irene Rosellini, Meri Barbafieri, Elisabetta Franchi, Roberto Bagatin . Assessment of repeated harvests on mercury and arsenic phytoextraction in a multi-contaminated industrial soil. AIMS Environmental Science, 2017, 4(2): 187-205. doi: 10.3934/environsci.2017.2.187
    [7] Adam O'Keeffe, Erin Brooks, Chad Dunkel, Dev S. Shrestha . Soil moisture routing modeling of targeted biochar amendment in undulating topographies: an analysis of biochar's effects on streamflow. AIMS Environmental Science, 2023, 10(4): 529-546. doi: 10.3934/environsci.2023030
    [8] Ioannis Panagopoulos, Athanassios Karayannis, Georgios Gouvalias, Nikolaos Karayannis, Pavlos Kassomenos . Chromium and nickel in the soils of industrial areas at Asopos river basin. AIMS Environmental Science, 2016, 3(3): 420-438. doi: 10.3934/environsci.2016.3.420
    [9] M.A. Rahim, M.G. Mostafa . Impact of sugar mills effluent on environment around mills area. AIMS Environmental Science, 2021, 8(1): 86-99. doi: 10.3934/environsci.2021006
    [10] Hamdy E. Nour, Fatma Ramadan, Nouf El Shammari, Mohamed Tawfik . Status and contamination assessment of heavy metals pollution in coastal sediments, southern Kuwait. AIMS Environmental Science, 2022, 9(4): 538-552. doi: 10.3934/environsci.2022032
  • Targeting inhibitory immune checkpoint molecules has highlighted the need to find approaches enabling the induction and activation of an immune response against cancer. Therapeutic vaccination, which can induce a specific immune response against tumor antigens, is an important approach to consider. Although this approach has shown low clinical efficacy when combined with other treatment modalities, therapeutic cancer vaccines will have a better outcome when combined with immune checkpoint blockade therapy with potential for cancer free survival. In this review, we will discuss the results of our two recent publications in preclinical lung cancer models. Our studies reveal that anti-PD-1 administered in combination with CCL21-DC tumor antigen therapeutic vaccines eradicate lung cancer. The results of these studies highlight the importance of combination therapy of immune checkpoint blockade and therapeutic cancer vaccines for lung cancer patients.



    In the human body, the heart controls the flow of blood through various blood vessels. Blood vessels are divided into arteries, capillaries, and veins according to their functions. Arteries transport fresh oxygen from the heart to all tissues in the body. The coronary artery system is composed of two blood vessels that diverge from the aorta. They are very close to the starting point of the heart. According to reports, coronary artery disease is the leading global cause of mortality and morbidity [1,2,3]. Unfortunately, accurate prediction and assessment of mortality or morbidity remains difficult due to the complexity of the interdependence of various factors and the ambiguity of the data. Compared with the traditional binary logistic regression model to predict the mortality after coronary artery bypass surgery, the fuzzy expert system introduced by Nouei et al. can greatly improve the classification accuracy [4]. Auffret et al. discussed the incidence, prognostic impact, and unmet needs of patients with new conduction disorders after transcatheter aortic valve replacement, as well as the ongoing challenges associated with the management of concomitant coronary artery disease [5]. Coronary angiography is the process of using X-rays to determine and observe the heart condition. It is the main imaging technique for diagnosing coronary diseases and is the standard for evaluating clinically significant coronary artery disease [6,7,8,9]. The 3D reconstruction of rotational coronary angiography can provide the required information volume for clinical applications [10]. Automatic 3D blood vessel reconstruction to improve vascular diagnosis and treatment is a challenging task, where real-time implementation of automatic segmentation and specific vascular tracking for matching artery sequences are essential [11,12]. Since most of the vascular interventional robots cannot cope with the complicated coronary artery lesions in clinical practice, the risk of surgery will be increased. Yu et al. developed a vascular interventional robot that can accurately measure the delivery resistance of interventional instruments and provide tactile force feedback to doctors [13].

    As we all know, more and more attention has been paid to non-autonomous dynamical systems in various fields of research, including ecology (such as describing the growth and competition relationships of biological populations), economics (such as describing the delayed response to market demand), and control theory (such as describing control systems with time-varying characteristics and delayed feedback). In practical applications, non-autonomous delayed differential equations can help us to understand and predict the dynamical behavior of the system more accurately. Non-autonomous differential equations can also be used to describe multi-agent systems and design corresponding control protocols [14,15]. The profound discussion of the coronary artery system as a practical biological mathematical case of the non-autonomous system is of great significance. The dynamics of a two-dimensional non-autonomous coronary artery model is investigated. Numerical simulations show that the system exhibits chaotic attractors, quasi-periodic attractors, and periodic orbits. For some specific parameter sets, two different solutions appear, and these coexisting attractors exhibit different complexity. It indicates that the dynamical characteristics of the coronary artery system are difficult to predict [16]. Many medical experts have concluded that vasospasm is the main cause of myocardial ischemia and other cardiovascular diseases, such as common angina pectoris, sudden death, myocardial infarction, etc. From the mathematical perspective, vascular spasm is caused by the chaotic state of blood vessels [17,18,19]. Singh et al. suggested that the chaotic states of abnormal vasospasm in blood vessels make heart disease patients more susceptible to severe COVID-19 infections, ultimately leading to high mortality rates [20].

    Bifurcation is always an important topic in nonlinear dynamics research [21], which can lead to some complex dynamical phenomena. The Hopf bifurcation is an important research area of non-autonomous delayed differential equations in the field of nonlinear dynamics, which has been widely applied to biology, physics, economics, and so on. However, the Hopf bifurcation of non-autonomous systems is very difficult to predict even in deterministic conditions. As a result, there are not many theories on it. Due to the sensitivity to disturbances, abnormal and fatal chaos in the system can induce coronary artery disease. In view of the signification of the dynamics of the coronary artery system, extensive researches have been conducted on it. By designing a chaotic observer and constructing a Lyapunov-Krasovskii functional (LKF) for the master-slave system, a more conservative synchronization strategy was obtained for chaotic coronary artery systems with state estimation errors and synchronization errors [22]. Ding et al. utilized disturbance observer technology to discuss the chaotic suppression of the coronary artery system, and designed a smooth second-order sliding mode controller to suppress the chaos of the coronary artery system [23]. Chantawat and Botmart were the first to investigate the finite-time H-infinity synchronization control for the coronary artery chaotic system with input and state time-varying delays [24]. They designed a synchronous feedback controller with good performance in the presence of disturbance and time-varying delay. This synchronization strategy can effectively synchronize the convulsive coronary artery system with the healthy cardiovascular system. From an engineering perspective, Qian et al. adopted a combination of the derivative-integral terminal sliding mode controller and disturbance observer to suppress chaos [25]. The simulation results verified the effectiveness of the proposed strategy. The adaptive feedback scheme combining linear state feedback and adaptive laws can also lead an abnormal muscular blood vessel to a normal track [26]. The coronary artery system is a complex biological system. Their chaotic phenomenon can lead to serious health problems. In order to suppress chaotic phenomena, various control methods have been proposed, such as an adaptive observer [27], self-tuning integral-type finite-time-stabilized sliding mode control [28], synchronization controller [29], generalized dissipative control method [30], terminal sliding mode control with self-tuning [31], etc. In fact, most of these researches involve suppressing chaos or synchronizing hemodynamics in the coronary artery system. However, there are not many explorations on the dynamics of coronary artery systems with periodic disturbances under certain parameter changes. Therefore, further researches on this system is of great significance.

    As an important physiological structure in the human body, muscular blood vessels are involved in many aspects such as blood flow. Many diseases, such as angina pectoris and myocardial infarction, are associated with abnormal dynamics of muscular blood vessels. By studying the dynamical phenomena of muscular blood vessel models, we can explore the cause and development of these diseases, and provide new ideas and methods for disease prevention and treatment. From the mathematical perspective, vascular spasm is caused by the chaotic state of blood vessels. Chaos shows that under certain conditions, the system suddenly deviates from the expected regularity and becomes disordered. Vasospasm is the manifestation of this disorder in the vascular system, which can cause blood vessel blockage in serious cases, thus endangering human health. So through the analysis of dynamical phenomena, we can deepen our understanding of these physiological mechanisms, more accurately diagnose related diseases, and make more effective treatment plans.

    The structure of this article is outlined as follows. In Section 2, we introduce the model of the S-type muscular blood vessel. In Section 3, we discuss its steady-state equations. Then we utilize recurrence plots to further validate the dynamics for different parameters [32,33]. Finally, bifurcation, chaos, and their numerical verifications are presented. In Section 4, we introduce the model of the N-type muscular blood vessel and obtain its bifurcation diagram from periodic to chaotic motions under different parameter changes. Section 5 presents a brief conclusion.

    The model of the S-type muscular blood vessel is denoted as [34]

    {dxdt=λ(y+xx3+dydt),dydt=cxby. (2.1)

    The system can be considered as

    d2ydt2+(cλbλ)y(t)(λcλb)dydt+λb3c2y(t)3+λc2(dydt)3+3bλc2y(t)(dydt)2+3λb2c2y(t)2dydt=0. (2.2)

    By introducing periodic disturbance and delay, System (2.2) becomes

    d2ydt2+(cλbλ)y(t)μ(λcλb)dydt+μλb3c2y(t)3+μλc2(dydt)3+μ3bλc2y(t)(dydt)2+μ3λb2c2y(t)2dydtεγcos(Ωt)y(tτ)=0, (2.3)

    where y is the change of the internal diameter of the vessel, x is the change of the internal pressure of the vessel and the time lag term is considered as a possible backflow caused by the vascular blockage, and εγcos(Ωt)y(tτ) is a combination of periodic stimulating disturbances with the time-delayed variation in the vessel internal diameter.

    The parameters of Eq (2.3) are suitably scaled as μ=ϵˆμ,ε=ϵˆε. In order to obtain an approximate solution of Eq (2.3), we utilize the method of multiple scales to seek the solution in the following form:

    {y(t,ϵ)=y0(T0,T1)+ϵy1(T0,T1)+O(ϵ2),y(tτ,ϵ)=yτ0(T0,T1)+ϵyτ1(T0,T1)+O(ϵ2), (3.1)

    where T0=t and T1=ϵt are two time scales. The derivatives can be written as follows:

    dydt=yT0+ϵyT1+O(ϵ2),d2ydt2=2yT20+2ϵ2yT0T1+O(ϵ2). (3.2)

    Substituting Eqs (3.1) and (3.2) into Eq (2.3), then equating the coefficients of like powers of ϵ, we obtain the following two differential equations,

    O(ϵ0):

    2T20y0+(cλbλ)y0=0, (3.3)

    O(ϵ1):

    2T20y1+(cλbλ)y1=ˆμλb3c2y30+γˆεcos(Ωt)yτ0ˆμ(λ+cλ+b)T0y0ˆμ3λb2c2y20T0y0                              ˆμ3bλc2y0(y0T0)2ˆμλc2(y0T0)322y0T0T1. (3.4)

    The solution for Eq (3.3) can be represented as

    y0(T0,T1)=A(T1)eiωT0+ˉA(T1)eiωT0. (3.5)

    The corresponding time-delayed solutions can be formulated as follows:

    yτ0(T0,T1)=A(T1ϵτ)eiω(T0τ)+ˉA(T1ϵτ)eiω(T0τ), (3.6)

    where over-bars represent the complex conjugate. Expanding A(T1ϵτ) in the Taylor series yields

    A(T1ϵτ)=A(T1)ϵτA(T1)+(ϵτ1)22!A(T1)(ϵτ)33!A(T1)+=A(T1)+O(ϵ). (3.7)

    Substituting Eq (3.7) into Eq (3.6) and by retaining only the first terms as approximations, therefore

    yτ0(T0,T1)A(T1)eiω(T0τ)+ˉA(T1)eiω(T0τ). (3.8)

    Substituting Eqs (3.5) and (3.6) into Eq (3.4) and taking Eq (3.8) into account, it follows that

    2T20y1+(cλbλ)y1=(b3λˆμ(eiT0ωA+eiT0ωˉA)3c2γˆεcos(Ωt)(ei(T0τ)ωA+ei(T0τ)ωˉA)+(bλ+cλ)                              ×ˆμ(ieiT0ωωAieiT0ωωˉA)+3b2λˆμ(eiT0ωA+eiT0ωˉA)2(ieiT0ωωAieiT0ωωˉA)c2+                              λˆμ(ieiT0ωωAieiT0ωωˉA)3c2+2(ieiT0ω×ωAieiT0ωωˉA)                              +3bλˆμ(eiT0ωA+eiT0ωˉA)(ieiT0ωωAieiT0ωωˉA)2c2). (3.9)

    Since Eq (3.5) is the solution of Eq (3.3), we have ω=cλbλ. The resonance here is 2:1 resonance, i.e., (Ω=2ω). Substituting (3.5) and (3.8) into (3.4), and utilizing the solvability conditions using the original time scale (i.e., ˆμ=μϵ,ˆε=εϵ), it follows that

    12eiωτγεˉA+ibμωAiλμωA+icλμωA+3b3λμc2A2ˉA+3ib2λμωc2A2ˉA+3bλμω2c2A2ˉA+3iλμω3c2A2ˉA+2iωA=0. (3.10)

    Expressing A in terms of the polar form, it follows that

    {A=a2eiϕ˙A=˙a2eiϕ+ia2˙ϕeiϕ,ˉA=a2eiϕ˙ˉA=˙a2eiϕia2˙ϕeiϕ, (3.11)

    in the equation, a is the amplitude and ϕ is the phases of System (2.3). Substituting Eq (3.11) into Eq (3.10) and equating the real parts of the equation to each other and separately equating the imaginary parts, we get the following equations:

    {˙a=a8c2ω(3λμω(b2+ω2)a2+2c2(2(b+(1+c)λ)μω+γεsin(ωτ2ϕ))),˙ϕ=18c2ω(3bλμ(b2+ω2)a22c2γεcos(ωτ2ϕ)). (3.12)

    In the steady state, there exists

    ˙a=˙ϕ=0. (3.13)

    From Eq (3.12), it follows that

    {a8c2ω(3λμω(b2+ω2)a2+2c2(2(b+(1+c)λ)μω+γεsin(ωτ2ϕ)))=0,18c2ω(3bλμ(b2+ω2)a22c2γεcos(ωτ2ϕ))=0. (3.14)

    The steady-state solution of Eq (3.14) can be numerically obtained via the software MATHEMATICA. In order to analyze the stability of the solution, we can let

    a=a0+a1,  ϕ=ϕ0+ϕ1, (3.15)

    where a0,ϕ0 satisfy Eq (3.14), and a1,ϕ1 are small-valued perturbations compared to a0,ϕ0. Inserting Eq (3.15) into Eq (3.12) and linearizing it at (a0,ϕ0), we get the following linear dynamical system:

    (˙a1˙ϕ1)=[J](a1ϕ1)=(r11r12r21r22)(a1ϕ1), (3.16)

    where [J]=(r11r12r21r22) is the Jacobian matrix. The characteristic equation reads as

    λ2+η1λ+η0=0. (3.17)

    The steady-state solution is asymptotically stable if and only if the real parts of all the eigenvalues λ are negative. According to the Routh-Hurwitz criterion, the sufficient and necessary conditions for ensuring that all roots of Eq (3.17) possess negative real parts is

    η1>0,η0>0. (3.18)

    Within this subsection, the bifurcation diagrams are produced on the basis of Eq (3.14). Analysis is introduced by using the following values of the system parameters: μ=1,ε=1,c=1.6,b=1,λ=1.6,τ=1,ω=2.6,γ=0.9, unless otherwise stated.

    Figure 1(a) are the γ-amplitude curves of approximate solutions by MMS, while Figure 1(b) compares the approximate analytical solution derived by using MMS with numerical simulation results. The figure reveals that as γ decreases gradually, the amplitude of periodic oscillations decreases accordingly. Until point A is reached, where the periodic oscillations cease to exist, this leaves only one unstable equilibrium in the system. From Figure 2, it is evident that the system exhibits a periodic solution for γ=0.67, and there exists a phase-locked solution for γ=0.66. As γ gradually decreases, it can be seen from Figure 2(h) that for γ=0.4, the system exhibits a quasi-periodic solution. Figure 2(i) presents the process from periodic to quasi-periodic solutions.

    Figure 1.  (a) The γ-amplitude response curves of the approximate solutions of System (2.3) for λ=1; (b) Comparisons between the approximate analytical solution derived using MMS and the numerical simulation results. Red dots: numerical solutions, solid lines: stable solutions, dashed lines: unstable solutions.
    Figure 2.  The evolution of System (2.3) for λ=1 with initial functions with y(0)=y(τ)=z(0)=z(τ)=0.1, where z(t)=˙y(t). (a),(b) γ=0.67; (c),(d) γ=0.66; (e) Poincarˊe section with section ˙z=0.5 for γ=0.66; (f),(g) γ=0.4; (h) Poincarˊe section with section ˙z=0.5 for γ=0.4; (i) the process of System (2.3) from periodic to quasi-periodic solutions.

    Figure 3 depicts a bifurcation diagram, where λ serves as the primary bifurcation parameter. As λ is decreased gradually, prior to reaching point A, System (2.3) possesses a single asymptotically stable equilibrium. However, at point A, a supercritical bifurcation takes place. Subsequent to this bifurcation, there is a stable periodic solution that is marked with a solid line and an unstable equilibrium marked with dashed lines. Figure 4(a),(b) demonstrate the time history and pseudo-phase portrait for λ=2.03, respectively, revealing the presence of a single asymptotically stable equilibrium at this stage. Following a supercritical Hopf bifurcation, Figure 4(c),(d) illustrate the time history and pseudo-phase portrait of System (2.3) at λ=1.98, indicating that System (2.3) possesses a stable periodic solution. Then the small-amplitude periodic solutions increase at a remarkable rate from Point A to Point B where the stable periodic solution disappears. Figure 4(e) reveals that System (2.3) may enter into a chaotic state for λ=0.6. Figure 4(f) shows the process of System (2.3) from periodic to chaotic motion when λ decreases from 0.73 to 0.6. Figure 5 describes the recurrence plots for λ=0.6 and λ=1.98. Generally speaking, when the recurrence plot presents a periodic shape, it reflects that the system is in a periodic state. When there are line segments parallel to the main diagonal and separate points mixed together, it is in a chaotic state. It can also be inferred from the figure that it is a periodic solution for λ=1.98, while it has chaotic motions for λ=0.6.

    Figure 3.  (a) The λ-amplitude response curves of the approximate solutions of System (2.3) for ω=2.6λ; (b) Comparisons between the approximate analytical solution derived using MMS and the numerical simulation results. Red dots: numerical solutions, solid lines: stable solutions, dashed lines: unstable solutions.
    Figure 4.  The numerical simulations of System (2.3) with the initial functions with x(0)=x(τ)=y(0)=y(τ)=0.1, where z(t)=˙y(t). (a), (b) λ=2.03; (c), (d) λ=1.98; (e) λ=0.6; (f) the process of System (2.3) from periodic to chaotic motions.
    Figure 5.  Recurrence plots of (a) a periodic motion for λ=1.98, (b) the chaotic motion for λ=0.6.

    Figure 6 illustrates the dynamical phenomena of System (2.3) with the change of parameter c, along with a comparison between the approximate analytical solution obtained through MMS and the numerical simulation results. It can be observed that as the parameter c gradually decreases to point A, a supercritical Hopf bifurcation takes place, resulting in the bifurcation from the asymptotically stable equilibrium to a stable periodic solution and an unstable equilibrium.

    Figure 6.  (a) The c-amplitude response curves of the approximate solutions of System (2.3) for ω=1.6(c+1); (b) Comparisons between the approximate analytical solution derived using MMS and the numerical simulation results. Red dots: numerical solutions, solid lines: stable solutions, dashed lines: unstable solutions.

    The numerical simulation presented in Figure 7 describes that c=1.77 before the bifurcation is an asymptotically stable equilibrium, as shown in Figure 7(c),(d). After the bifurcation Point A, for c=1.75, there is a stable periodic solution as represented in Figure 7(a),(b). As c continues to decrease, the amplitude of the periodic solution continuously increases until it reaches Point B. Subsequent to Point B, the periodic solution disappears, and as presented in Figure 7(e)(g), the quasi-periodic solution appears for c=1.29.

    Figure 7.  The numerical simulations of System (2.3) with the initial functions with x(0)=x(τ)=y(0)=y(τ)=0.1, where z(t)=˙y(t). (a), (b) c=1.75; (c), (d) c=1.77; (e), (f) c=1.29; (g) Poincarˊe section with section ˙z=0.6 for c=1.29; (h) the process of System (2.3) from periodic to quasi-periodic solutions.

    As shown in Figure 8, supercritical Hopf bifurcation will occur at Point A and produce a stable periodic solution, but as b gradually decreases, the stable periodic solution disappears at Point B. From Figure 8(b), it can be seen that the approximate analytical solution obtained by MMS is in good agreement with the numerical simulation results, indicating the effectiveness of MMS. Figure 9 proves that there exists asymptotically stable equilibrium before the bifurcation point and there exists a stable periodic solution after bifurcation, which verifies the bifurcation results shown in Figure 8.

    Figure 8.  (a) The b-amplitude response curves of the approximate solutions of System (2.3) for λ=0.5,τ=0.2,ω=0.5(1.6b); (b) Comparisons between the approximate analytical solution derived using MMS and the numerical simulation results. Red dots: numerical solutions, solid lines: stable solutions, dashed lines: unstable solutions.
    Figure 9.  The numerical simulations of System (2.3) with the initial functions with x(0)=x(τ)=y(0)=y(τ)=0.1, where z(t)=˙y(t). (a), (b) b=0.25; (c), (d) b=0.3.

    In medicine, blood vessels can be divided into the N-type and the S-type according to the shape of the blood vessels (see Appendix). By a series of equivalent transformation, the biological mathematical model of the N-type muscular blood vessel can be described as follows [17,19]:

    {dxdt=λ(y+y3x)+λdydt+uy(tτ)cos(ωt),dydt=eyfx. (4.1)

    Thus there can be

    d2ydt2(fλeλ)y(t)+(λ+fλ+e)dydt+fλy(t)3+fucos(ωt)y(tτ)=0, (4.2)

    where y represents the change of the internal diameter of the vessel, x represents the change of the internal pressure of the vessel and the time lag term is considered as a possible backflow caused by the vascular blockage and fucos(ωt)y(tτ) is a combination of periodic stimulating disturbances with the time-delayed variation in the vessel internal diameter.

    In this subsection, System (4.2) is analyzed numerically by the software WinPP. The parameters are as follows: e=0.15,f=1.7,λ=0.65,u=2,τ=0.1,ω=1.

    Figure 10 depicts the dynamical phenomena of System (4.2) based on different values of u. According to Figure 10(a), System (4.2) is in stable periodic motion and exhibits a normal health case for u=0.335. The figures for u=0.345, u=0.35, and u=0.3513 are illustrated in Figure 10(b)(d), respectively, which show that with the increase of u, System (4.2) gradually becomes Period-2, Period-4, and Period-8 periodic motions. Figure 10(e),(f) indicate that chaos will occur for u=0.38 and the system becomes more complex, which will cause vascular spasm and endanger health. Figure 10(h) describes that as u increases from 0.3 to 0.4, the system will gradually transfer from ordered periodic motion to disordered, complex chaotic motion through period-doubling bifurcation.

    Figure 10.  Route of period-doubling bifurcation to chaos of System (4.2) as u increases gradually for ω=1.1 with initial functions with y(0)=y(τ)=z(0)=z(τ)=0.1, where z(t)=˙y(t). (a) u=0.335; (b) u=0.345; (c), u=0.35; (d) u=0.3513; (e),(f),(g) u=0.38; (g) Poincarˊe section with section ˙z=0.48; (h) System (4.2) transitions from an ordered periodic motion to a disordered, complex chaotic motion by period-doubling bifurcation.

    Figure 11(h) illustrates a bifurcation diagram with ω as the bifurcation parameter. From the four pseudo-phase portraits in Figure 11(a)(d), it can be seen that with the gradual increase of ω, System (4.2) undergoes a transition from Period-1 to Period-2, then to Period-4, and finally to Period-8, which indicates the period-doubling bifurcation phenomenon. Figure 11(e),(f) shows that for ω=2.18, System (4.2) is in chaotic motion. Therefore, it can be shown that when ω gradually increases in the range of 2.01 to 2.22, System (4.2) transfers from periodic solutions to chaos through period-doubling bifurcation.

    Figure 11.  Route of period-doubling bifurcation to chaos of System (4.2) as ω increases gradually with initial functions with y(0)=y(τ)=z(0)=z(τ)=0.1, where z(t)=˙y(t). (a) ω=2.05; (b) ω=2.1; (c) ω=2.135; (d) ω=2.14; (e), (f) ω=2.18; (g) Poincarˊe section with section ˙z=0.5 for ω=2.18; (h) System (4.2) transitions from an ordered periodic motion to a disordered, complex chaotic motion by period-doubling bifurcation.

    Figure 12 describes the motions of System (4.2) with ω ranging of 1.241.3. The red points in Figure 12(a)(c) are the Poincarˊe section with section ˙z=0. As ω gradually decreases, System (4.2) goes from Period-2 to Period-4 and then to Period-8 periodic motions, ultimately leading to chaos. Such chaos is very dangerous to health and must be controlled and eliminated immediately.

    Figure 12.  Route of period-doubling bifurcation to chaos of System (4.2) as ω increases gradually with initial functions with y(0)=y(τ)=z(0)=z(τ)=0.1, where z(t)=˙y(t). (a) ω=1.3; (b) ω=1.28; (c) ω=1.267; (d) ω=1.25; (e) Poincarˊe section with section ˙z=0 for ω=1.25; (f) System (4.2) transitions from an ordered periodic motion to a disordered, complex chaotic motion by period-doubling bifurcation.

    Figure 13(a) is the pseudo-phase portrait for τ=0.5, where the red dots represent the Poincarˊe section with section ˙z=0. In this case, System (4.2) is in Period-2 periodic motion. As τ gradually increases, Figure 13(b) illustrates a Period-3 periodic motion for τ=0.66. For τ=0.7 and τ=0.8, System (4.2) is in Period-6 and Period-5 periodic motions, respectively. As τ continues to increase, the system returns to Period-3 periodic motion, but subsequently changes into chaotic motion. In Figure 14, as τ gradually decreases, System (4.2) undergoes a period-doubling bifurcation from Period-4 to Period-8 periodic motions, then to Period-16 periodic motion, and finally leads to chaos.

    Figure 13.  The bifurcation of System (4.2) as τ increases gradually with initial functions with y(0)=y(τ)=z(0)=z(τ)=0.1, where z(t)=˙y(t). (a) τ=0.5; (b) τ=0.66; (c) τ=0.7; (d) τ=0.8; (e) τ=1; (f) τ=1.15; (g) Poincarˊe section with section ˙z=0 for τ=1.15; (h) System (4.2) transitions from an ordered periodic motion to a disordered, complex chaotic motion by period-doubling bifurcation.
    Figure 14.  Route of period-doubling bifurcation to chaos of System (4.2) as τ increases gradually with initial functions with y(0)=y(τ)=z(0)=z(τ)=0.1, where z(t)=˙y(t). (a) τ=1.45; (b) τ=1.37; (c) τ=1.33; (d) τ=1.27; (e) Poincarˊe section with section ˙z=0 for τ=1.27; (f) System (4.2) bifurcates from an ordered periodic motion to a disordered, complex chaotic motion by period-doubling bifurcation of Period-4 periodic solutions.

    Figure 15 shows the motions of System (4.2) at different f. As can be seen from the figure, System (4.2) gradually changes from Period-2 to Period-5 periodic motions, then to Period-10 periodic motion, and finally leads to a dangerous chaotic motion.

    Figure 15.  The bifurcation of System (4.2) as c increases gradually with initial functions with y(0)=y(τ)=z(0)=z(τ)=0.1, where z(t)=˙y(t). (a) f=5; (b) f=4.2; (c) f=3.6; (d) f=3; (e) Poincarˊe section with section ˙z=0 for f=3; (f) System (4.2) from an ordered periodic motion to a disordered, complex chaotic motion.

    Two non-autonomous systems with time delay, The models of the N-type and the S-type muscular blood vessels, are investigated. From the above analysis, we can draw the following conclusion:

    1). In order to discuss the complex dynamical behaviors of the systems, the method of multiple scales is utilized to analyze the periodic solutions of the systems, and their stability is judged by the Routh-Hurwitz criterion. It displays that the MMS can get better analytical results.

    2). By observing bifurcation diagrams, the time histories and pseudo-phase portraits, we uncovered various dynamical phenomena exhibited by the systems under different parameters, including equilibrium, periodic solutions, quasi-periodic solutions, chaos, as well as the route to chaos from period-doubling bifurcations.

    3). The N-type muscular blood vessel system is more complex and chaotic, and the risk of disease is increased. But the chaotic characteristics of the S-type muscular blood vessel system is not so strong.

    4). The effects of different parameters on two systems are obtained. In the N-type muscular blood vessel model, the larger u is between 0.3 and 0.4, the more complex the motion of the system. It will enter a chaotic state at about 0.375, resulting in vascular spasm. The system is dangerously chaotic with the time delay τ between 1.126 and 1.32. In the S-type muscular blood vessel model, the greater the value of γ at the right side of Point A in Figure 1, the greater the amplitude of the periodic solution. On the left side of Point A, the motion state of the system gradually attains quasi-periodic solutions as γ decreases. This work provides a reference for understanding vascular diseases and guidance to treat these vascular diseases.

    In this paper, Hopf bifurcation and chaos of two muscular blood vessel systems affected by external disturbances are researched by the MMS, and abundant dynamical phenomena are obtained. In the future, we will try to research the double Hopf bifurcation of non-autonomous systems with time-varying coefficients.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    This work was supported by the National Natural Science Foundation of China under Grant No. 11972327.

    The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

    Xu and Liu [34] described a mechanical model with concentrated parameters for muscular vessels:

    dδRdt=h(12πLR20+R316μL2)δPR20P04πL2δR, (5.1)
    {h=PaPb2πP0R408μL,δR=RR0,δP=PP0, (5.2)
    dδPdt=φ(δRδP)+KdδRdt, (5.3)

    where |δR|R0, |δP|P0.

    For the N-type vessels,

    {φ(δR,δP)=γ[ψ(δR)δP],ψ(δR)=1αδR(1δRδR1)(1+δRδR2). (5.4)

    For the S-type vessels,

    {φ(δR,δP)=β[δRϕ(δP)],ϕ(δP)=αδP(1δPδP1)(1+δPδP2), (5.5)

    where α,β,γ,K,δR1,2 and δP1,2 are normal numbers. Then, based on the above model, they organized the following the N-type blood vessel models:

    {dxdt=λ(y+y3x)+λdydt,dydt=eyfx, (5.6)

    and the S-type blood vessel models:

    {dxdt=λ(y+xx3+dydt),dydt=cxby, (5.7)

    where y represents the change of the internal diameter of the vessel and x represents the change of the internal pressure of the vessel.


    Acknowledgments



    Financial disclosure: This work was supported by VA Merit Award I01BX003171.

    Ethical disclosure



    All animal work was conducted in accord with the Veterans Affairs Institutional Animal care and Use Committee guidelines: id D16-00002. The Animal Care and Use Committee review board approved all the studies involving animals.

    Conflict of interest



    All the authors declare that there are not biomedical financial interests or potential conflicts of interest in writing this manuscript.

    [1] Fitzmaurice C, Abate D, Abbasi N, et al. (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5: 1749-1768. doi: 10.1001/jamaoncol.2019.2996
    [2] Nerviani A, Pitzalis C (2018) Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer. J Leukoc Biol 104: 333-341. doi: 10.1002/JLB.3MR0218-062R
    [3] Colbeck EJ, Ager A, Gallimore A, et al. (2017) Tertiary lymphoid structures in cancer: drivers of antitumor immunity, immunosuppression, or bystander sentinels in disease? Front Immunol 8: 1830. doi: 10.3389/fimmu.2017.01830
    [4] Lee JM, Lee MH, Garon E, et al. (2017) Phase I trial of intratumoral injection of CCL21 gene-modified dendritic cells in lung cancer elicits tumor-specific immune responses and CD8(+) T-cell infiltration. Clin Cancer Res 23: 4556-4568. doi: 10.1158/1078-0432.CCR-16-2821
    [5] Ancevski Hunter K, Socinski MA, Villaruz LC (2018) PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer. Mol Diagn Ther 22: 1-10. doi: 10.1007/s40291-017-0308-6
    [6] Brahmer JR, Govindan R, Anders RA, et al. (2018) The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC). J Immunother Cancer 6: 75. doi: 10.1186/s40425-018-0382-2
    [7] Diskin B, Adam S, Cassini MF, et al. (2020) PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer. Nat Immunol 21: 442-454. doi: 10.1038/s41590-020-0620-x
    [8] Freeman GJ, Long AJ, Iwai Y, et al. (2000) Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192: 1027-1034. doi: 10.1084/jem.192.7.1027
    [9] Cyster JG (1999) Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J Exp Med 189: 447-450. doi: 10.1084/jem.189.3.447
    [10] Kadam P, Singh RP, Davoodi M, et al. (2020) Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine. Vaccines (Basel) 8: 655. doi: 10.3390/vaccines8040655
    [11] Kadam P, Sharma S (2020) PD-1 immune checkpoint blockade promotes therapeutic cancer vaccine to eradicate lung cancer. Vaccines (Basel) 8: 317. doi: 10.3390/vaccines8020317
    [12] Kadam P, Singh R, Davoodi M, et al. (2020) Immune checkpoint blockade enhances immune activity of therapeutic lung cancer vaccine. Vaccines (Basel) 8: 655. doi: 10.3390/vaccines8040655
    [13] Hollingsworth RE, Jansen K (2019) Turning the corner on therapeutic cancer vaccines. NPJ Vaccines 4: 7. doi: 10.1038/s41541-019-0103-y
    [14] Mougel A, Terme M, Tanchot C (2019) Therapeutic cancer vaccine and combinations with antiangiogenic therapies and immune checkpoint blockade. Front Immunol 10: 467. doi: 10.3389/fimmu.2019.00467
    [15] Jou J, Harrington KJ, Zocca MB, et al. (2021) The changing landscape of therapeutic cancer vaccines-novel platforms and neoantigen identification. Clin Cancer Res 27: 689-703. doi: 10.1158/1078-0432.CCR-20-0245
    [16] Del Re M, Rofi E, Restante G, et al. (2018) Implications of KRAS mutations in acquired resistance to treatment in NSCLC. Oncotarget 9: 6630-6643. doi: 10.18632/oncotarget.23553
    [17] Varghese AM, Sima CS, Chaft JE, et al. (2013) Lungs don't forget: comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers. J Thorac Oncol 8: 123-125. doi: 10.1097/JTO.0b013e31827914ea
    [18] Riely GJ, Kris MG, Rosenbaum D, et al. (2008) Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clin Cancer Res 14: 5731-5734. doi: 10.1158/1078-0432.CCR-08-0646
    [19] Subramanian J, Govindan R (2007) Lung cancer in never smokers: a review. J Clin Oncol 25: 561-570. doi: 10.1200/JCO.2006.06.8015
    [20] Du Y, Cui X, Sidorenkov G, et al. (2020) Lung cancer occurrence attributable to passive smoking among never smokers in China: a systematic review and meta-analysis. Transl Lung Cancer Res 9: 204-217. doi: 10.21037/tlcr.2020.02.11
    [21] Couraud S, Zalcman G, Milleron B, et al. (2012) Lung cancer in never smokers—a review. Eur J Cancer 48: 1299-1311. doi: 10.1016/j.ejca.2012.03.007
    [22] Cheng ES, Egger S, Hughes S, et al. (2021) Systematic review and meta-analysis of residential radon and lung cancer in never-smokers. Eur Respir Rev 30. doi: 10.1183/16000617.0230-2020
    [23] Alexandrov LB, Ju YS, Haase K, et al. (2016) Mutational signatures associated with tobacco smoking in human cancer. Science 354: 618-622. doi: 10.1126/science.aag0299
    [24] Blackford A, Parmigiani G, Kensler TW, et al. (2009) Genetic mutations associated with cigarette smoking in pancreatic cancer. Cancer Res 69: 3681-3688. doi: 10.1158/0008-5472.CAN-09-0015
    [25] Hodi FS, O'day SJ, Mcdermott DF, et al. (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363: 711-723. doi: 10.1056/NEJMoa1003466
    [26] Topalian SL, Hodi FS, Brahmer JR, et al. (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366: 2443-2454. doi: 10.1056/NEJMoa1200690
    [27] Robert C, Thomas L, Bondarenko I, et al. (2011) Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 364: 2517-2526. doi: 10.1056/NEJMoa1104621
    [28] Alexander M, Galeas J, Cheng H (2018) Tumor mutation burden in lung cancer: a new predictive biomarker for immunotherapy or too soon to tell? J Thorac Dis 10: S3994-S3998. doi: 10.21037/jtd.2018.09.35
    [29] Willis C, Fiander M, Tran D, et al. (2019) Tumor mutational burden in lung cancer: a systematic literature review. Oncotarget 10: 6604-6622. doi: 10.18632/oncotarget.27287
    [30] Westcott PM, Halliwill KD, To MD, et al. (2015) The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature 517: 489-492. doi: 10.1038/nature13898
    [31] Conway JR, Kofman E, Mo SS, et al. (2018) Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine. Genome Med 10: 93. doi: 10.1186/s13073-018-0605-7
    [32] Zappasodi R, Merghoub T, Wolchok JD (2018) Emerging concepts for immune checkpoint blockade-based combination therapies. Cancer Cell 33: 581-598. doi: 10.1016/j.ccell.2018.03.005
    [33] Simon S, Labarriere N (2017) PD-1 expression on tumor-specific T cells: friend or foe for immunotherapy? Oncoimmunology 7: e1364828. doi: 10.1080/2162402X.2017.1364828
    [34] Tumeh PC, Harview CL, Yearley JH, et al. (2014) PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515: 568-571. doi: 10.1038/nature13954
  • Reader Comments
  • © 2021 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2994) PDF downloads(124) Cited by(0)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog